Symbol search
date o news sym
fool
09:46 Sat 12
Nws
Why Do the Wealthy Pay Such Low Taxes?
Here's how the super-rich get away with dodging the IRS -- legally.
https://www.fool.com/taxes/2021/06/12/why-do-the-wealthy-pay-such-low-taxes/?source=iedfolrf0000001


fool
11:03 Fri 19
Nws
The Secret to Getting Into the 0% Tax Bracket
You may be able to legally ditch taxes if you do this.
https://www.fool.com/taxes/2021/02/19/the-secret-to-getting-in-the-0-tax-bracket/?source=iedfolrf0000001
PAGS
Techn
upi
19:00 Tue 14
AnlyRtAnlyCl
Study: Moderna COVID-19 vaccine immunity lasts 6 months
Immunity from the Moderna COVID-19 vaccine lasts for at least six months, and there is no indication that fully vaccinated people will need a booster shot, a small study published Tuesday by Science found.
https://www.upi.com/Health_News/2021/09/14/covid19-moderna-vaccine-booster-unneeded-study/3011631641058/
MRNA
Healt
Text search
date o news
news google au
02:27 Wed 22
Nws
Spikevax (Moderna) COVID-19 vaccine available in pharmacies - Australian Government Department of Health
Spikevax (Moderna) COVID-19 vaccine available in pharmacies    Australian Government Department of Health Close contacts of COVID-positive truck driver who travelled through SA identified as Moderna vaccine rolls out    ABC News New vaccine jabs open for SA over-12s and over-60s    InDaily 22 Toowoomba pharmacies now offering Moderna vaccine    Chronicle Queensland begins Moderna COVID vaccine rollout | 7NEWS    7NEWS Australia View Full coverage on Google News
MRNA
Healt
nytimes
00:06 Fri 24
Nws
Moderna vs. Pfizer: Both Knockouts, but One Seems to Have the Edge
A series of studies found that the Moderna vaccine seemed to be more protective as the months passed than the Pfizer-BioNTech vaccine. Heres why.
MRNA
Healt
nanoappsmedical
12:34 Fri 24
Waning immunity and COVID-19 vaccines: How worried should we be?
Research has found a significant fall in levels of antibodies against SARS-CoV-2, the virus that causes COVID-19, 6 months after the second dose of the Pfizer-BioNTech vaccine. Clinical evidence also suggests that the risk of getting a breakthrough infection gradually increases in the months after vaccination. Despite declines in antibody levels, other branches of [...]


marketwatch
12:16 Fri 24
TrdId
: Whether COVID-19 boosters get approved or not, Pfizer and Moderna have already made their money
It's likely that millions of COVID-19 booster shots will be administered in the U.S. in the coming months, but that doesnt mean companies like Moderna and Pfizer will report an unexpected revenue windfall this year.
MRNA
Healt
upi
15:00 Fri 24
One-third of initially vaccine hesitant ultimately obtain COVID-19 shot, study finds
Nearly one in three people who reported being reluctant to obtain the COVID-19 vaccine ultimately received at least one dose, a study published Friday by JAMA Network Open found.


boston
13:42 Wed 22
Nws
Moderna vs. Pfizer: Both Knockouts, but One Seems to Have the Edge
A series of studies found that the Moderna vaccine seemed to be more protective over the long term than the Pfizer-BioNTech vaccine. Heres why. The post Moderna vs. Pfizer: Both knockouts, but one seems to have the edge appeared first on Boston.com .
MRNA
Healt
rt
09:58 Thu 23
Nws
Covid-19 pandemic will be over in a year, Moderna chief executive says
The CEO of US pharma giant Moderna, Stephane Bancel, has come up with a reassuring forecast, suggesting that increasing vaccine production could see the coronavirus pandemic finally coming to an end in mid-2022. Read Full Article at RT.com
MRNA
Healt
mirror co uk
1h ago
Nws
Covid pandemic could be over in a year with 'return to normal', vaccine boss predicts
The chief executive of the company who produced the Moderna vaccine, Stphane Bancel, said a boost in Covid jab production will mean there's enough for "everyone on this Earth" by next year


benzinga
13:16 Fri 24
Nws
Sinovac's COVID-19 Vaccine Shows Efficacy, But Lags Rivals In Malaysian Study: Reuters
According to a real-world study from Malaysia,  Sinovac Biotech Ltd's  (NASDAQ: SVA ) COVID-19 vaccine, CoronaVac, showed effectiveness against serious illness.  However, shots from  Pfizer Inc  (NYSE: PFE ) /  BioNTech SE  (NASDAQ:  BNTX ) and  AstraZeneca plc  (NASDAQ: AZN ) demonstrated better protection rates,  reported Reuters . The latest data boosts Sinovac's COVID-19 vaccine that has been under scrutiny over its effectiveness following reports of infections among fully immunized healthcare ... Full story available on Benzinga.com
SVA

feedburner
11:14 Fri 24
Sinovacs COVID-19 vaccine highly effective against serious illness: study
Sinovacs COVID-19 vaccine is highly effective against serious illness, although rival shots from Pfizer/BioNTech and AstraZeneca showed better protection rates, a large real world study from Malaysia showed. The latest data is a boost to the Chinese firm, whose COVID-19 vaccine has been under growing scrutiny over its effectiveness following reports of infections among healthcare workers fully immunized with the Sinovac shot in Indonesia and Thailand. The study, conducted by the Malaysian government, found that 0.011% of about 7.2 million recipients of the Sinovac shot required treatment in intensive care units (ICU) for COVID-19 infections, health officials told reporters on Thursday. By contrast, 0.002% of about 6.5 million recipients of the Pfizer/BioNTech vaccine needed ICU treatment for COVID-19 infections, while 0.001% of 744,958 recipients of the AstraZeneca shot required similar treatment. Kalaiarasu Peariasamy, a director at the Institute for Clinical Research that conducted the study along with a national COVID-19 taskforce, said vaccinations regardless of the brand have reduced the risk of admission to intensive care by 83% and lowered the risk of death by 88% based on a smaller study involving about 1.26 million people. The breakthrough rate for intensive care unit admission is extremely low, he said, adding overall ICU admissions among fully vaccinated individuals stood at 0.0066%. Mortality rate of the fully vaccinated people was also low at 0.01% and the majority of them were either above 60 years of age or with comorbidities. There were differences in the demographics of the recipients of the three vaccines and it could have resulted in the different results, Kalaiarasu said. Many of AstraZeneca recipients were in the mid-adulthood age, while the Pfizer and Sinovac shots were very much for the vulnerable population, he said. AstraZeneca recipients also accounted for a much smaller proportion of the study, which involved about 14.5 million fully vaccinated individuals and conducted for more than five months since April 1. In July, Malaysia said it will stop administering the Sinovac vaccine once its supplies end, as it has a sufficient number of other vaccines for its programme. The Sinovac vaccine has been widely used in several countries including China, Indonesia, Thailand and Brazil, and the company said earlier this month it had supplied 1.8 billion doses at home and abroad. Malaysia has fully vaccinated 58.7% of its 32 million population and gave at least one dose to 68.8%. The post Sinovacs COVID-19 vaccine highly effective against serious illness: study appeared first on ARY NEWS . from ScienceTechnology ARY NEWS https://ift.tt/3CGc9Rj https://ift.tt/eA8V8J


@MarketCurrents
13:44 Fri 24
Nws
$MRNA - Moderna inks 20M dose COVID-19 vaccine supply deal with Peru https://t.co/Ms4HhV2KXJ
-
MRNA
Healt
huffpost
10:40 Fri 24
Nws
Moderna CEO Predicts End Of COVID-19 Pandemic Within A Year
Many lower-income nations are still waiting on their first vaccine doses.
MRNA
Healt
businessdailyafrica
21:00 Thu 23
Nws
Natural immunity against covid-19 isa powerful weapon
More than 15 studies have demonstrated the power of natural immunity acquired by previously...


boston
21:50 Fri 24
NwsRmrs
Massachusetts makes COVID-19 vaccine booster available at 460 locations
For now, the appointments are only available to eligible groups that got the Pfizer vaccine at least six months ago. The post Massachusetts makes COVID-19 vaccine booster available at 460 locations appeared first on Boston.com .


@guardian
03:52 Fri 24
TrdId
Victoria Covid update: Moderna vaccine to be rolled out as Brett Sutton sounds AFL grand final warning https://t.co/zQZcQUt1hE
-
MRNA
Healt
@guardiannews
04:13 Fri 24
TrdId
Victoria Covid update: Moderna vaccine to be rolled out as Brett Sutton sounds AFL grand final warning https://t.co/xWQVBn6XEd
-
MRNA
Healt
news google
20:34 Thu 23
Nws
CDC panel authorizes COVID-19 vaccine boosters for high-risk people, those over 65 - The Hill
CDC panel authorizes COVID-19 vaccine boosters for high-risk people, those over 65    The Hill Man punches nurse in the face multiple times after his wife is vaccinated for Covid    CNN CDC director recommends COVID-19 booster for younger at-risk workers, defying advisory panel    Fox News Children aren't able to give informed consent until they turn 18 but they can assent or dissent befo    VERIFY Only 16 Countries Have Vaccinated 70 Percent of Population, Minimum for COVID Herd Immunity    Newsweek View Full Coverage on Google News


news-medical net
15:12 Fri 24
Nws
Further evidence of safety and efficacy of mRNA-1273 vaccine in preventing symptomatic COVID-19 and SARS-CoV-2 infection
A recent study supports the efficacy of the mRNA-1273 vaccine in preventing COVID-19 illness and disease severity.


boston
21:50 Fri 24
Nws
Massachusetts opens up COVID-19 vaccine booster appointments at 460 locations
For now, the appointments are only available to eligible groups that got the Pfizer vaccine at least six months ago. The post Massachusetts opens up COVID-19 vaccine booster appointments at 460 locations appeared first on Boston.com .


theborneopost
14:27 Fri 24
Nws
No vaccine wastage in Malaysia Khairy
PUTRAJAYA (Sept 24): There has been no wastage of the Covid-19 vaccine in Malaysia, said Health Minister Khairy Jamaluddin. Speaking on vaccine inequity, he said Malaysia currently uses Covid-19 vaccine stocks that are available in the country just to make sure more people are vaccinated. “That is why we have not announced (Covid-19) vaccine third [...]


mothership sg
14:23 Thu 23
Nws
Vaccinated pregnant women pass protection to babies: Study
36 newborns tested at birth were found to all have antibodies to protect against Covid-19, after their mothers were vaccinated with shots from Pfizer-BioNTech or Moderna.


cnn
14:28 Fri 24
Nws
CDC breaks with advisers on Covid booster recommendations
LIVE UPDATES: Biden says scientists are still analyzing data for Moderna and Johnson & Johnson vaccine boosters


delapcpa
16:37 Thu 23
Success That Lasts Episode 67: Proposed Tax Changes for 2022
In this episode of Success That Lasts, Jared Siegel discusses the recently proposed federal tax changes for 2022. Tune in here, at delapcpa.com/podcast, or wherever you listen to podcasts: Here are a few highlights: The proposal includes a new top ordinary income tax bracket of 39.6%. This rate would apply to a single filer […] The post Success That Lasts Episode 67: Proposed Tax Changes for 2022 appeared first on Delap .


countingpips
14:00 Fri 24
Nws
Dynavax Shares Shoot Up 30% After Its Partner Clover Biopharma Met All Key Efficacy Endpoints in Ph. 2/3 COVID-19 Vaccine Trial
Source: Streetwise Reports 09/22/2021 Shares of Dynavax Technologies Corp. established a new 52-week high after the company reported that in the global Phase 2/3 SPECTRA COVID-19 vaccine study its collaborative partner Clover Biopharmaceuticals met all primary and secondary efficacy endpoints. Clover’s vaccine, which was developed using Dynavax’s CpG 1018 adjuvant, demonstrated 100% efficacy against severe […]
DVAX
Healt
news google
13:45 Fri 24
NwsRmrs
Does My State Have a COVID-19 Vaccine App? - PCMag
Does My State Have a COVID-19 Vaccine App?    PCMag I chose not to get the vaccine: BC COVID-19 patient pleads with others to get vaccinated    Global News NY COVID latest: Friday, September 24, 2021    WPIX 11 New York 3 East Bay School Districts Go All-In on COVID-19 Vaccine Mandates    KPIX CBS SF Bay Area Eyewitness News Special: What's new, what's next for COVID-19 vaccines and boosters    WABC-TV View Full Coverage on Google News


the-scientist
14:25 Fri 24
Nws
Moderna vs. Pfizer: Is There a Best mRNA Vaccine?
Both of the mRNA vaccines available in the US are highly effective against severe COVID-19, but recent studies suggest that Modernas elicits a stronger immune response and might be better at preventing breakthrough infections.
MRNA
Healt
pharmashots
08:41 Fri 24
Nws
Pfizer and BioNTechs COVID-19 Vaccine Booster Receive the US FDAs EUA for the Treatment of COVID-19
Shots: The US FDA has issued a EUA for the COVID-19 booster vaccine (administered at least 6mos. after completion of primary 2 doses) to prevent COVID-19 in individuals aged 65yrs. & 18 through 64yrs. of age who at high risk of severe COVID-19 The EUA is based on clinical data that showed higher neutralizing Ab […] The post Pfizer and BioNTechs COVID-19 Vaccine Booster Receive the US FDAs EUA for the Treatment of COVID-19 first appeared on PharmaShots .


malaymail
14:14 Fri 24
Nws
Khairy says no Covid-19 vaccine wastage in Malaysia
PUTRAJAYA, Sept 24 There has been no wastage of the Covid-19 vaccine in Malaysia, said Health Minister Khairy Jamaluddin. Speaking on vaccine inequity, he said Malaysia currently uses Covid-19 vaccine stocks that are available in the country...


cnn
05:48 Fri 24
Covid-19 vaccine boosters can begin for older, higher-risk people in the US
Following days of lengthy debate among vaccine experts, booster shots of the Pfizer/BioNTech Covid-19 vaccine can now be officially administered to some adults in the United States.


scimex org
15:00 Fri 24
TrdId
Two in three hesitant people shift to say 'yes' to vaccine
Covid-19 vaccine hesitancy waned between late 2020 and early 2021, in a US study of more than 3,000 people. Nearly one in three who were first hesitant had been vaccinated, and more than one in three moved to being willing to be jabbed, when they were surveyed again in March-April 2021. The remainder said they were still unlikely to get the jab. The authors note that vaccines weren't available to all who took part until after the follow-up survey, which is a limitation.